134136-00-8 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate is used as a building block in organic synthesis for the preparation of various pharmaceutical and biologically active molecules. Its unique structure and functional groups contribute to the development of new drugs and therapeutic agents.
Used in Antimicrobial Applications:
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate is used as an antimicrobial agent, exhibiting activity against a range of microorganisms. Its ability to inhibit microbial growth makes it a potential candidate for the development of new antimicrobial drugs and treatments.
Used in Anticancer Applications:
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate is used as an anticancer agent, showing potential in targeting and inhibiting the growth of cancer cells. Its biological activities may contribute to the development of novel cancer therapies and treatment strategies.
Used in Research and Development:
Ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate is used in research and development for the discovery and design of new drugs and therapeutic agents. Its unique properties and potential applications make it a valuable tool in the advancement of pharmaceutical sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 134136-00-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,1,3 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 134136-00:
(8*1)+(7*3)+(6*4)+(5*1)+(4*3)+(3*6)+(2*0)+(1*0)=88
88 % 10 = 8
So 134136-00-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N2O2S/c1-2-14-9(13)6-3-4-7-8(5-6)15-10(11)12-7/h6H,2-5H2,1H3,(H2,11,12)
134136-00-8Relevant articles and documents
FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS ROR GAMMA MODULATORS
-
, (2015/07/16)
The present invention provides fused thiophene and thiazole derivatives of formula (I), which may be therapeutically useful, more particularly as RORγ modulators; in which R1, R2, R3, R4, R5, R6, R7, X1, X2, L, m, n and ring A have the meanings given in the specification, and pharmaceutically acceptable salts thereof that are useful in the treatment and prevention of diseases or disorders, in particular their use in disease(s) or disorder(s) where there is an advantage in modulating RORγ receptor. The present invention also provides preparation of the compounds and pharmaceutical formulations comprising at least one of the fused thiophene and thiazole derivatives of formula (I), together with a pharmaceutically acceptable carrier, diluent or excipient therefor.
ANTI-INFECTIVE COMPOUNDS
-
, (2016/06/28)
The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.
BENZAMIDE COMPOUNDS AS GLUCOKINASE ACTIVATORS AND THEIR PHARMACEUTICAL APPLICATION
-
, (2011/09/14)
Benzamide compounds of formula (I), their stereoisomers, tautomers, prodrugs, pharmaceutically acceptable salts, polymorphs, solvates and formulations thereof useful as Glucokinase activators or modulators are disclosed. The disclosure further relates to
INTERMEDIATES FOR THE PREPARATION OF PRAMIPEXOLE
-
Page/Page column 17, (2010/02/14)
Intermediates useful for the preparation of pramipexole and the use thereof in such synthesis.
